HOME › DRUGS › GLOFITAMAB
ACTIVE SUBSTANCE / INN

GLOFITAMAB

Brand name(s): Columvi
EMA LISTED
AUTHORISED
Lymphoma, Large B-Cell, Diffuse
ACTIVE SUBSTANCE
Glofitamab
REGULATORS
EMA
SPONSORS / MAH
Roche Registration GmbH 
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ColumviRoche Registration GmbH Authorised07/07/2023Lymphoma, Large B-Cell, Diffuse

FULL INTELLIGENCE ON GLOFITAMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →